检索结果-南通市图书馆

Liver cancer incidence and mortality in China, 2009

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer 2013年第4期32卷 162-169页

作者： Wan-Qing Chen rong-shou zheng Si-Wei Zhang National Office for Cancer Prevention and Control &National Cancer Center

Liver cancer is a common cancer and a leading cause of cancer deaths in China. To aid the government in establishing a control plan for this disease, we provided real-time surveillance information by analyzing liver cancer incidence and mortality in China in 2009 reported by the National Central Cancer Registry. Liver cancer incidence and cases of death were retrieved from the national database using the ICD-10 topography code "C22". Crude incidence and mortality were calculated and stratified by sex, age, and location (urban/rural). China's population in 1982 and Segi (world) population structures were used for age-standardized rates. In cancer registration areas in 2009, the crude incidence of liver cancer was 28.71/100,000, making it the fourth most common cancer in China, third most common in males, and fifth most common in females. The crude mortality of liver cancer was 26.04/100,000, making it the second leading cause of cancer death in China and urban areas and the third leading cause in rural areas. Incidence and mortality were higher in males than in females and were higher in rural areas than in urban areas. The age-specific incidence and mortality were relatively low among age groups under 30 years but dramatically increased and peaked in the 80 -84 years old group. These findings confirm that liver cancer is a common and fatal cancer in China. Primary and secondary prevention such as health education, hepatitis B virus vaccination, and early detection should be carried out both in males and females, in urban and rural areas.

关键词： Liver cancer, cancer registry, incidence, mortality, China

Synergy of metal-support interaction and positive Pd species promoting efficient C-CI bond activation on Pd-based Ce-MOF-derived catalysts

在线全文

学校读者我要写书评

暂无评论

Rare Metals 2024年第11期43卷 5835-5847页

作者： Xiao-Jie Hu Yu-Han Sun Ling-Yue Liu Dan-Jun Mao shou-rong zheng State Key Laboratory of Pollution Control and Resource Reuse School of the EnvironmentNanjing UniversityNanjing 210023China Department of Applied Biology and Chemical Technology The Hong Kong Polytechnic UniversityHong Kong 999077Hong KongChina

Monochloroacetic acid(MCAA)is identified as a highly carcinogenic disinfection by-product in chlorinated drinking *** this study,a series of CeO_(2)-supported Pd catalysts(Pd/MCeO_(2))were synthesized through one-step calcination of Pd-loaded Ce-UiO-66-BDC(CeMOF),and the liquid-phase catalytic hydrodechlorination of MCA A was explored using these *** comparison,Pd/CeO_(2)catalysts were additionally synthesized using the conventional impregnation *** characterization results reveal that the catalysts exhibit strong metal-support interaction,leading to high Pd dispersion and Pd^(n+)***,the calcination temperature significantly influences catalytic performance,with the catalyst calcined at 500℃(Pd/MCeO_(2)-500)demonstrating the highest catalytic activity and achieving complete dechlorination of MCA A within 50 ***,it is found that the catalytic MCAA hydrodechlorination using the catalysts adheres to the Langmuir-Hinshelwood ***,low reaction pH is favorable for the catalytic hydrodechlorination of MCAA,enhancing MCAA adsorption on the catalyst surface due to the electrostatic interaction between MCAA and the catalyst *** results suggest that the presence of Pd^(n+)efficiently facilitates MCAA adsorption and C-Cl cleavage,thus significantly enhancing the liquid-phase catalytic hydrodechlorination.

关键词： Ce-UiO-66-BDC One-step calcination Metal-support interaction Liquid-phase catalytic hydrodechlorination Monochloroacetic acid

Cancer Incidence and Mortality in China,2007

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer Research 2012年第1期24卷 1-8页

作者： Wan-qing Chen Hong-mei Zeng rong-shou zheng Si-wei Zhang Jie He National Office for Cancer Prevention and Control/National Central Cancer Registry Cancer InstituteChinese Academy of Medical SciencesBeijing 100021China

Objective： Cancer incidence and mortality data collected from population-based cancer registries were analyzed to present the overall cancer statistics in Chinese registration areas by age, sex and geographic area in 2007. Methods： In 2010, 48 cancer registries reported cancer incidence and mortality data of 2007 to National Central Cancer Registry of China. Of them, 38 registries＇ data met the national criteria. Incidence and mortality were calculated by cancer sites, age, gender, and area. Age-standardized rates were described by China and World population. Results： The crude incidence rate for all cancers was 276.16/100,000 （305.22/100,000 for male and 246.46/100,000 for female; 284.71/100,000 in urban and 251.07/100,000 in rural）. Age-standardized incidence rates by China and World population were 145.39/100,000 and 189.46/100,000 respectively. The crude mortality rate for all cancers was 177.09/100,000 （219.15/100,000 for male and 134.10/100,000 for female; 173.55/100,000 in urban and 187.49/100,000 in rural）. Age-standardized mortality rates by China and World population were 86.06/100,000 and 116.46/100,000, respectively. The top 10 most frequently common cancer sites were the lung, stomach, colon and rectum, liver, breast, esophagus, pancreas, bladder, brain and lymphoma, accounting for 76.12% of the total cancer cases. The top 10 causes of cancer death were cancers of the lung, liver, stomach, esophagus, colon and rectum, pancreas, breast, leukemia, brain and lymphoma, accounting for 84.37% of the total cancer deaths. Conclusion： Cancer remains a major disease threatening people＇s health in China. Prevention and control should be enhanced, especially for the main cancers.

关键词： Cancer registry Incidence Mortality China

Nasopharyngeal carcinoma incidence and mortality in China in 2010

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer 2014年第8期33卷 381-387页

作者： Kuang-rong Wei rong-shou zheng Si-Wei Zhang Zhi-Heng Liang Zhi-Xiong Ou Wan-Qing Chen Cancer Institute of Zhongshan People’s Hospital Zhongshan Guangdong National Center for Cancer Registration National Cancer CenterBeijing

Nasopharyngeal carcinoma(NPC) is common in South China. Although regional epidemiological data on NPC in China is available, national epidemiological data have been unavailable up to now. The goal of this study was to analyze the NPC incidence and mortality data in some domestic cancer registries, estimate these rates in China in 2010, and provide scientific information that can be harnessed for NPC control and prevention. To accomplish this goal, NPC incidence and mortality data for 2010 were collected from 145 Chinese cancer registries from which data were included in the 2013 National Cancer Registry Annual Report. Such indices as its incident and death numbers, crude rates, age-standardized rates and truncated rates were calculated and analyzed. The incidence and mortality in China and constituent areas were estimated according to the national population in 2010. An estimated 41,503 new cases and 20,058 deaths were attributed to NPC in China in 2010, accounting for 1.34% of all new cancer cases and 1.03% of all cancer-related deaths that year in China. Crude incidence and mortality were 3.16/100,000 and 1.53/100,000, respectively. World age-standardized incidence and mortality were 2.44/100,000 and 1.18/100,000, respectively. Incidence and mortality were higher among males than among females and slightly higher in urban areas than in rural areas. Among seven Chinese administrative regions, NPC incidence and mortality were obviously higher in South China than in other regions and lowest in North China. The male and female age-specific incidence and mortality both rose quickly from age 25-29 years, but peaked at different ages and varied by location. These results demonstrated that NPC incidence and mortality in China especially in South China were at high levels in the world, and suggested that control and prevention efforts should be enhanced.

关键词：中国南方死亡率发病率鼻咽癌全国人民代表大会人口估计流行病学控制工作

Nasopharyngeal carcinoma incidence and mortality in China in 2009

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer 2013年第8期32卷 453-460页

作者： Zhi-Jian Xu rong-shou zheng Si-Wei Zhang Xiao-Nong Zou Wan-Qing Chen Cancer Screening Center Cancer Hospital Chinese Academy of Medical Sciences National Office for Cancer Prevention and Control & National Cancer Center

Nasopharyngeal carcinoma (NPC) is rare globally but common in China and exhibits a distinct ethnic and geographic distribution. In 2009, the National Central Cancer Registry in China provided real-time surveillance information on NPC. Individual NPC cases were retrieved from the national database based on the ICD-10 topography code C11. The crude incidence and mortality of NPC were calculated by sex and location (urban/rural). China's population in 1982 and Segi's world population structures were used to determine age-standardized rates. In regions covered by the cancer registries in 2009, the crude incidence of NPC was 3.61/100,000 (5.08/100,000 in males and 2.10/100,000 in females; 4.19/100,000 in urban areas and 2.42/100,000 in rural areas). Age-standardized incidences by Chinese population (ASIC) and Segi's world population (ASIW) were 2.05/100,000 and 2.54/100,000, respectively. The crude mortality of NPC was 1.99/100,000 (2.82/100,000 in males and 1.14/100,000 in females; 2.30/100,000 in urban areas and 1.37/100,000 in rural areas). The age-standardized mortalities by Chinese population (ASMC) and world population (ASMW) were 1.04/100,000 and 1.35/100,000, respectively. The incidence and mortality of NPC were higher in males than in females and higher in urban areas than in rural areas. Both agespecific incidence and mortality were relatively low in persons younger than 30 years old, but these rates dramatically increased. Incidence peaked in the 60-64 age group and mortality peaked in the over 85 age group. Primary and secondary prevention, such as lifestyle changes and early detection, should be carried out in males and females older than 30 years of age.

关键词：中国人口死亡率发病率鼻咽癌全国人民代表大会农村地区世界人口年龄组

Incidence and mortality of liver cancer in China in 2011

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer 2015年第11期34卷 508-513页

作者： Ting-Ting Zuo rong-shou zheng Si-Wei Zhang Hong-Mei Zeng Wan-Qing Chen National Central Cancer Registry National Cancer Center

Background: Liver cancer is a common cancer with poor prognosis in China. In this study, the national population?based cancer registration data were used to evaluate and analyze liver cancer incidence and mortality in China in 2011 and provide a reference for liver cancer prevention and ***: We collected and evaluated the incidence and mortality data of liver cancer in 2011 from 177 cancer registries with qualiied data. These data were used in the inal analysis including calculating crude, standardized, and truncated incidences and mortalities, and estimated new liver cancer cases and deaths using age?speciic rates and the corresponding populations. The national census in 2000 and Segi's population were used for age?standardized ***: The estimates of new liver cancer cases and deaths were 355,595 and 322,416, respectively, in China in 2011. The crude incidence, age?standardized rate of incidence by Chinese standard population(ASRIC), and age?stand?ardized rate of incidence by world standard population(ASRIW) of liver cancer were 26.39/100,000, 19.48/100,000, and 19.10/100,000, respectively; the crude mortality, age?standardized rate of mortality by Chinese standard popula?tion(ASRMC), and age?standardized rate of mortality by world standard population(ASRMW) of liver cancer were 23.93/100,000,17.48/100,000, and 17.17/100,000, respectively. The incidence and mortality were higher in rural areas than in urban areas and higher in males than in females. The age?speciic incidence and mortality of liver cancer increased greatly with age, particularly after 30 years and peaked at 80–84 or 85+ ***: Liver cancer is a common cancer in China, particularly for males and residents in rural areas. Targeted prevention, early detection, and treatment programs should be carried out.

关键词： Liver cancer, Incidence, Mortality, China

Nasopharyngeal carcinoma incidence and mortality in China,2013

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer 2017年第12期36卷 686-693页

作者： Kuang-rong Wei rong-shou zheng Si-Wei Zhang Zhi-Heng Liang Zhu-Ming Li Wan-Qing Chen Cancer Institute of Zhongshan People’s Hospital ZhongshanGuangdong 528403P.R.China National Central Cancer Registry National Cancer CenterBeijing 100021P.R.China

Background: We estimated the incidence and mortality of nasopharyngeal carcinoma(NPC) in China in 2010 according to the data of 145 domestic population-based cancer registries in 2014, and no such reports since ***, to further and better understand its epidemiology in China and to provide more precise scientific information for its control and prevention in China, we analyzed the NPC incidence and mortality of 255 domestic populationbased cancer registries, and estimated the national rates in 2013 ***: NPC incidence and mortality data of 255 domestic cancer registries in 2013, accepted by the 2016 National Cancer Registry Annual Report, were collected and collated, and the indices of NPC such as the numbers of new cases and deaths, crude rates, age-standardized rates, and truncated rates of incidence and mortality were calculated and analyzed. The incidence and mortality in China and its constituent areas were estimated according to the national population in ***: An estimated 42,100 new cases and 21,320 deaths were attributed to NPC in China in 2013, accounting for1.14% of all new cancer cases and 0.96% of all cancer-related deaths that year in China. Crude incidence and mortality of NPC were 3.09/100,000 and 1.57/100,000, respectively. World age-standardized incidence and mortality were2.17/100,000 and 1.08/100,000, respectively. The incidence and mortality of males were obviously higher than those of females and slightly higher in urban areas than in rural areas. Among seven Chinese administrative regions, NPC incidence and mortality were obviously higher in South China than in other regions and lowest in North China. Top3 incidence and mortality provinces and registering areas all located in South China. The age-specific incidence and mortality rose quickly from age 25-29 and 35 to 39 years, respectively, peaked at different ages and varied by ***: These results demonstrated that NPC incidence and mortality in China in

关键词： Nasopharyngeal carcinoma Incidence Mortality China

The incidences and mortalities of major cancers in China, 2010

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer 2014年第8期33卷 402-405页

作者： Wan-Qing Chen rong-shou zheng Si-Wei Zhang Hong-Mei Zeng Xiao-Nong Zou National Central Cancer Registry National Cancer CenterBeijing

To estimate the cancer incidences and mortalities in China in 2010, the National Central Cancer Registry(NCCR) of China evaluated data for the year of 2010 from 145 qualified cancer registries covering 158,403,248 people(92,433,739 in urban areas and 65,969,509 in rural areas). The estimates of new cancer cases and cancer deaths were 3,093,039 and 1,956,622 in 2010, respectively. The percentage of morphologically verified cases were 67.11%; 2.99% of incident cases were identified through death certification only, with the mortality to incidence ratio of 0.61. The crude incidence was 235.23/100,000(268.65/100,000 in males and 200.21/100,000 in females). The age-standardized rates by Chinese standard population(ASR China) and by world standard population(ASR world) were 184.58/100,000 and 181.49/100,000, respectively, with a cumulative incidence(0-74 years old) of 21.11%. The crude cancer mortality was 148.81/100,000(186.37/100,000 in males and 109.42/100,000 in females). The ASR China and ASR world were 113.92/100,000 and 112.86/100,000, respectively, with a cumulative mortality of 12.78%. Lung, breast, gastric, liver, esophageal, colorectal, and cervical cancers were the most common cancers. Lung, liver, gastric, esophageal, colorectal, breast, and pancreatic cancers were the leading causes of cancer deaths. The coverage of cancer registration has rapidly increased in China in recent years and may reflect more accurate cancer burdens among populations living in different areas. Given the increasing cancer burden in the past decades, China should strengthen its cancer prevention and control.

关键词：癌症发病率中国标准死亡率发生率世界标准 ASR 城市地区农村地区

Incidence and mortality of liver cancer in China, 2010

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer 2014年第8期33卷 388-394页

作者： Kuang-rong Wei Xia Yu rong-shou zheng Xia-Biao Peng Si-Wei Zhang Ming-Fang Ji Zhi-Heng Liang Zhi-Xiong Ou Wan-Qing Chen Cancer Institute Zhongshan Municipal People’s HospitalZhongshan Guangdong National Central Cancer Registry National Cancer CenterBeijing Digestive Internal Department Zhongshan Municipal People’s HospitalZhongshan Guangdong

Liver cancer is a common malignant tumor in China and a major health concern. We aimed to estimate the liver cancer incidence and mortality in China in 2010 using liver cancer data from some Chinese cancer registries and provide reference for liver cancer prevention and treatment. We collected and evaluated the incidence and mortality data of liver cancer in 2010 from 145 cancer registries, which were included in the 2013 Chinese Cancer Registry Annual Report, calculated crude, standardized, and truncated incidences and mortalities, and estimated new liver cancer cases and deaths from liver cancer throughout China and in different regions in 2010 from Chinese practical population. The estimates of new liver cancer cases and deaths were 358,840 and 312,432, respectively, in China in 2010. The crude incidence, age-standardized rate by Chinese standard population(ASR China), and age-standardized rate by world standard population(ASR world) were 27.29/100,000, 21.35/100,000, and 20.87/100,000, respectively; the crude, ASR China, and ASR world mortalities were 23.76/100,000, 18.43/100,000, and 18.04/100,000, respectively. The incidence and mortality were the highest in western regions, higher in rural areas than in urban areas, and higher in males than in females. The age-specific incidence and mortality of liver cancer showed a rapid increase from age 30 and peaked at age 80-84 or 85+. Our results indicated that the 2010 incidence and mortality of liver cancer in China, especially in undeveloped rural areas and western regions, were among high levels worldwide. The strategy for liver cancer prevention and treatment should be strengthened.

关键词：中国标准死亡率肝癌世界人口死亡病例恶性肿瘤西部地区农村地区